186 related articles for article (PubMed ID: 25535670)
1. In vitro immunomodulatory activity of interferon alpha on toll-like receptor 9 signaling pathway in chronic hepatitis B.
Wang X; Zhao YR; Liu HL; Ma XH; Zhang Y
J Interferon Cytokine Res; 2015 May; 35(5):385-91. PubMed ID: 25535670
[TBL] [Abstract][Full Text] [Related]
2. In vitro immunomodulatory activity of oxymatrine on Toll-like receptor 9 signal pathway in chronic hepatitis B.
Yao N; Wang X
Am J Chin Med; 2014; 42(6):1399-410. PubMed ID: 25406654
[TBL] [Abstract][Full Text] [Related]
3. Decreased expressions of Toll-like receptor 9 and its signaling molecules in chronic hepatitis B virus-infected patients.
Sajadi SM; Mirzaei V; Hassanshahi G; Khorramdelazad H; Daredor HY; Hosseini SM; Moogooi M; Ravary A; Arababadi MK; Kennedy D
Arch Pathol Lab Med; 2013 Nov; 137(11):1674-9. PubMed ID: 24168509
[TBL] [Abstract][Full Text] [Related]
4. Natural killer cells display impaired responses to toll like receptor 9 that support viral persistence in chronic hepatitis B.
Ratnam DT; Sievert W; Visvanathan K
Cell Immunol; 2012 Sep; 279(1):109-15. PubMed ID: 23123793
[TBL] [Abstract][Full Text] [Related]
5. Immunomodulatory effects of polysaccharopeptide (PSP) in human PBMC through regulation of TRAF6/TLR immunosignal-transduction pathways.
Li W; Liu M; Lai S; Xu C; Lu F; Xiao X; Bao Y
Immunopharmacol Immunotoxicol; 2010 Dec; 32(4):576-84. PubMed ID: 20131955
[TBL] [Abstract][Full Text] [Related]
6. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.
Chen M; Hu P; Ling N; Peng H; Lei Y; Hu H; Zhang D; Ren H
PLoS One; 2015; 10(3):e0120086. PubMed ID: 25774808
[TBL] [Abstract][Full Text] [Related]
7. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
[TBL] [Abstract][Full Text] [Related]
8. [Expression of TLR9 in peripheral blood mononuclear cells of hepatitis B patients].
Dou JH; Kong M; Wang CH; Jiao SX; Liu Q; Wen ZK
Zhonghua Gan Zang Bing Za Zhi; 2010 Jan; 18(1):61-2. PubMed ID: 20128973
[No Abstract] [Full Text] [Related]
9. Patients with chronic hepatitis B infection display deficiency of plasmacytoid dendritic cells with reduced expression of TLR9.
Xie Q; Shen HC; Jia NN; Wang H; Lin LY; An BY; Gui HL; Guo SM; Cai W; Yu H; Guo Q; Bao S
Microbes Infect; 2009 Apr; 11(4):515-23. PubMed ID: 19289178
[TBL] [Abstract][Full Text] [Related]
10. Recognition of Borrelia burgdorferi, the Lyme disease spirochete, by TLR7 and TLR9 induces a type I IFN response by human immune cells.
Petzke MM; Brooks A; Krupna MA; Mordue D; Schwartz I
J Immunol; 2009 Oct; 183(8):5279-92. PubMed ID: 19794067
[TBL] [Abstract][Full Text] [Related]
11. Deoxycytidyl-deoxyguanosine oligonucleotide classes A, B, and C induce distinct cytokine gene expression patterns in rhesus monkey peripheral blood mononuclear cells and distinct alpha interferon responses in TLR9-expressing rhesus monkey plasmacytoid dendritic cells.
Abel K; Wang Y; Fritts L; Sanchez E; Chung E; Fitzgerald-Bocarsly P; Krieg AM; Miller CJ
Clin Diagn Lab Immunol; 2005 May; 12(5):606-21. PubMed ID: 15879022
[TBL] [Abstract][Full Text] [Related]
12. Expression profiles and function of Toll-like receptors 2 and 4 in peripheral blood mononuclear cells of chronic hepatitis B patients.
Chen Z; Cheng Y; Xu Y; Liao J; Zhang X; Hu Y; Zhang Q; Wang J; Zhang Z; Shen F; Yuan Z
Clin Immunol; 2008 Sep; 128(3):400-8. PubMed ID: 18565796
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
[TBL] [Abstract][Full Text] [Related]
14. HBsAg inhibits TLR9-mediated activation and IFN-alpha production in plasmacytoid dendritic cells.
Xu Y; Hu Y; Shi B; Zhang X; Wang J; Zhang Z; Shen F; Zhang Q; Sun S; Yuan Z
Mol Immunol; 2009 Aug; 46(13):2640-6. PubMed ID: 19501403
[TBL] [Abstract][Full Text] [Related]
15. Reduced toll-like receptor 9 expression on peripheral CD14+ monocytes of chronic hepatitis B patients and its restoration by effective therapy.
Huang YW; Hsu CK; Lin SC; Wei SC; Hu JT; Chang HY; Liang CW; Chen DS; Chen PJ; Hsu PN; Yang SS; Kao JH
Antivir Ther; 2014; 19(7):637-43. PubMed ID: 24622882
[TBL] [Abstract][Full Text] [Related]
16. [Modulation of TLR9 on anti-tumor immune responses of peripheral blood mononuclear cells from patients with non-small-cell lung cancer].
Ren T; Cai YY; Liang YJ; Jin ML; Guo ZL; Tao MF; He X
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(17):1168-72. PubMed ID: 18844109
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of toll like receptor signaling molecules in chronic HBV infected patients.
Momeni M; Zainodini N; Bidaki R; Hassanshahi G; Daneshvar H; Khaleghinia M; Ebrahim M; Karimi-Googheri M; Askari A; Arababadi MK; Kennedy D
Hum Immunol; 2014 Jan; 75(1):15-9. PubMed ID: 24120739
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of TLR7/9 leads to deficient production of IFN-α from plasmacytoid dendritic cells in chronic hepatitis B.
Xu N; Yao HP; Lv GC; Chen Z
Inflamm Res; 2012 Sep; 61(9):997-1004. PubMed ID: 22684144
[TBL] [Abstract][Full Text] [Related]
19. Negative regulation of TLR9-mediated IFN-alpha induction by a small-molecule, synthetic TLR7 ligand.
Marshall JD; Heeke DS; Gesner ML; Livingston B; Van Nest G
J Leukoc Biol; 2007 Sep; 82(3):497-508. PubMed ID: 17565046
[TBL] [Abstract][Full Text] [Related]
20. Anti-HBV effects of CpG oligodeoxynucleotide-activated peripheral blood mononuclear cells from patients with chronic hepatitis B.
Li N; Fan XG; Chen ZH; Huang Y; Quan J; Liu ZB
APMIS; 2005 Oct; 113(10):647-54. PubMed ID: 16309422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
